The organ care products market is set to register exponential growth by 2028 due to the globally rising prevalence of chronic diseases that lead to organ failure. Prevalent adoption of advanced technologies, implementation of favorable policies, development of sophisticated medical infrastructure, and increasing number of transplantation procedures across the globe are set to augment industry uptake.

Organ care products offer enhanced productivity and convenience, which is slated to drive product demand through the study timeline.

Increasing number of transplantation procedures across the world have also prompted manufacturers and medical institutions to develop effective organ care systems to prolong organ storage time, especially in case there is a shortage in donor organs. These recent technological advancements will be fostering industry expansion over the past few years.

Notably, industry players have been engaging in lucrative strategies of recent to capitalize on these emerging trends, which has favorably impacted the global business outlook. For instance, in February 2021, Bridge to Life, Ltd., a major supplier of organ perfusion technologies and organ preservation solutions, announced its collaboration with Tevosol, Inc., a clinical-stage medical startup, to co-develop and commercialize innovative products for the organ transplantation community.

According to the deal, Bridge to Life agreed to invest in developing, testing, and commercializing Tevosol’s portable ex-vivo lung perfusion (EVLP) equipment and normothermic organ preservation platform.

The organ care products market has been segregated on the basis of product type, organ type, and region.
With respect to organ type, the market has further been classified into lungs, heart, liver, kidney, and others. The liver sub-segment was valued at around USD 18.0 million in 2021 and is expected to grow at robust pace through the assessment period. Excessive consumption of alcohol along with the growing incidence of diabetic patients suffering from liver failure is likely to boost product adoption in coming time period.

Based on product type, the organ care market has been bifurcated into portable and trolly. The trolly sub-segment accounted for a sizable revenue share of nearly 50% in 2021 and is anticipated to witness solid expansion over the forecast timeline.

From the regional point of view, the Latin America organ care products market is projected to progress at approximately 17.0% CAGR over the analysis period on account of improving access to developing technologies in clinical settings.

In addition, an increasing number of market players adopting several growth strategies to expand their business across emerging countries is speculated to propel market development. Furthermore, rising awareness among people regarding organ donation will likely fuel regional market growth over the forthcoming years.